glp 1 by medvi is showing what a new kind of company can look like A telehealth platform selling GLP-1 weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B MEDVi Under Fire: The $1.8
Description
Its an easy and enjoyable daily habit for everyone

GLP-1 medications like semaglutide reduce appetite and slow stomach emptying, which can create nutritional gaps

Although these findings are preliminary, some mechanistic models posit that GLP-1s could attenuate DMNactivity associated with food-related rumination, potentially altering the cognitive context in which eating decisions occur

Available with quick delivery and easy return options

Expert guide by Marie.

Worried about appetite suppressant side effects
